All SARS-CoV-2 articles – Page 11
-
NewsCovid variant JN.1 raises concerns with increased transmissibility and immune evasion
Researchers reveal genetic differences, increased infectivity, and vaccine resistance in the newly identified SARS-CoV-2 variant JN.1.
-
NewsMachine learning to battle COVID-19 bacterial co-infection
Researchers have used machine learning to help predict the risk of secondary bacterial infections in hospitalised COVID-19 patients.
-
NewsResin destroys coronavirus from plastic surfaces
A recent study found that a resin ingredient is effective against coronaviruses and strongly decreases their infectivity on plastic surfaces.
-
NewsBIPOC individuals bear greater post-COVID burdens
In a study, black and multiracial participants reported more days of lost work and health aftereffects when compared with white participants.
-
NewsGut microbiota influence severity of respiratory viral infection
The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, a new study reveals.
-
NewsDNA particles that mimic viruses hold promise as vaccines
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
-
NewsViral protein fragments may unlock mystery behind serious COVID-19 outcomes
‘Zombie’ virus fragments continue to cause inflammation after the virus is destroyed, a new study finds.
-
NewsScientists uncover how coronavirus defends itself against our immune system
A research team identifies “protective switches” in the protein of the SARS-CoV-2 virus.
-
NewsProtein may be the ‘glue’ that helps COVID virus stick
A study found that perlecan LG3 – a protein most commonly found in blood vessels and the brain – readily formed a stable bond with the COVID spike protein and perhaps enhanced the virus’ ability to bind with cells.
-
NewsInfants born to COVID-infected mums have triple risk of developing respiratory distress
Vaccinating mothers prior to infection significantly reduced the risk for full-term infants developing a breathing disorder that most often strikes premature newborns.
-
NewsStrong links found between long COVID and ME/CFS
People suffering from long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new study has found.
-
NewsScientists make COVID receptor protein in mouse cells
Initially motivated to make receptor-based sensors and therapies for COVID-19, scientists develop general strategy for producing other complex proteins.
-
NewsFIFA World Cup ends with win for Argentina - and COVID-19
The 2022 FIFA World Cup ended with a win for Argentina over France, but it was also a triumph for SARS-CoV-2 with a significant jump in the number of cases, some of which could have been prevented, a new study suggests.
-
NewsSpatial statistics experts warn that statistical proof of COVID-19 market theory is flawed
Huanan Seafood Wholesale Market in the Chinese city of Wuhan is not the only possible place of origin of the COVID-19 pandemic, a new study warns.
-
NewsHuman immune system evolves in the post-Omicron era
New research suggests that human immune responses are changing in order to combat the never-ending emergence of new SARS-CoV-2 variants.
-
NewsBlood analysis in patients finds characteristics of Long Covid
Analysis of blood samples from patients with Long Covid – a debilitating condition with unknown causes – has revealed serum protein changes as the likely culprit.
-
NewsSARS-CoV-2 can infect dopamine neurons, causing senescence
A new study has reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence - when a cell loses the ability to grow and divide.
-
NewsNew study to examine very rare adverse events linked to COVID-19 vaccines
A multimillion-dollar global initiative will study causes and risk factors, to ensure safer vaccines are ready for the next potential pandemic.
-
NewsVaccine speeds up the production of antibodies against Covid
A new vaccine uses preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2.
-
NewsGenotyping technology detects Covid variants more quickly and cheaply than ever
A new study reveals that the technique detects new variants almost a week more quickly than traditional whole genome sequencing methods.
